Downloads
-
NK Cell Therapies: How Artiva Biotherapeutics Leverages Its “Manufacturing First” Approach
4/24/2024
We caught up with Chris Horan, Artiva Biotherapeutics' CTO, to discuss natural killer cell therapies and Artiva’s experiences and strategies with its candidate, AlloNK.
-
Evaluating CAR T-Cell Therapy Vascular Recruitment, Trafficking, And Killing
4/24/2024
Learn about a more human-relevant platform that enables researchers to assess the trafficking and killing efficiency of immunotherapy as well as the proof-of-concept of immuno-oncology co-therapy.
-
Large-Scale API Production Services
4/23/2024
Ensuring commercial success at every juncture, we employ a consultative and phase-appropriate methodology that's tailored to your specific needs.
-
Highly Potent And Complex API Contract Manufacturing
4/23/2024
Equipped with a diverse array of scales, our seasoned experts possess the finesse and acumen necessary to tackle even the most intricate and potent API projects.
-
Simplify Your Linker-Payload Synthesis
4/23/2024
By streamlining the synthesis pathways, see how these products can effectively diminish the requisite number of developmental and manufacturing stages essential for generating payloads.
-
Environmental Monitoring Vs. Good Aseptic Technique
4/23/2024
Review the standards and regulations promoting a cohesive environmental program, and explore manual compounding in laminar flow hoods, through to filling lines, in both open and closed systems.
-
Improving Governance And Compliance With Knowledge Management
4/23/2024
Knowledge management — it’s not just a soulless exercise. In the last part of his series, Hirsh helps bridge the gap between compliance and business needs.
-
The FDA Modernization Act is Signed Into Law. Now What?
4/22/2024
Scientists worldwide celebrated the signing of the FDA Modernization Act into law. Gain expert insights into what to anticipate regarding using New Approach Methods (NAMs) in novel IND submissions.
-
Ex Vivo Systems: Translating Mechanisms To Human Oncology
4/22/2024
Watch to learn how Champions Oncology is advancing the development of oncology drugs through the creation of complex in vitro models using patient-derived TumorGrafts.
-
Democratizing Organ-On-A-Chip Technology
4/22/2024
Learn about CAR T-cell therapy as a promising cancer treatment, challenges in CAR T development for solid tumors, the advantages of modeling the holistic CAR T journey with Organ-Chips, and more.